Universal opt-out programs raise sexually transmitted infection screening rates in adolescents, though confidentiality issues may affect commercially insured patients.

The FDA has launched an online searchable database with information for consumers about chemical contaminants in foods.

A retrospective cohort study revealed that nicotinamide exposure among adults did not increase the risk for major adverse cardiovascular events.

A memo suggests that the government may end the CDC’s HIV Prevention Division, which tracks infections and promotes prevention.

Some patients with atopic dermatitis who qualify for advanced systemic therapies do not receive them or may lack improvement with these therapies.

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.

The Department of Health and Human Services has removed the 2024 surgeon general’s advisory on gun violence from its website.

The outbreak of measles began earlier this year in Gaines County, Texas, and has since spread to New Mexico and now Oklahoma.

Clinicians should familiarize themselves with the risk factors and clinical identifiers of familial sex trafficking.

The rate of neonatal intensive care unit has increased in recent years to nearly 1 in 10 infants being admitted in 2023.

Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.

The total age-adjusted injury death rate among Americans was higher in 2023 than in 2013, reaching a peak in 2021.